AstraZeneca launches $1.5 billion annual savings plan to invest in drug pipeline
Oct 30 (Reuters) – AstraZeneca on Friday launched an unexpected restructuring drive aimed at investing in its new drug pipeline, hoping that annual savings of about $1.5 billion from the plan will keep the drugmaker on track to achieve its long-term ambitions. The Anglo-Swedish drugmaker did not detail whether the plan would involve job cuts but said it expects the programme to result in one-time…
Open True Mainstream to compare left, right, and center coverage